Radiotherapy and radiosurgery for benign neurofibromas

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 3, 2005, Pages 317-320

  Chopra, Rahul ^a   Morris, Christopher G ^a   Friedman, William A ^a   Mendenhall, William M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Neurofibromas; Radiation therapy; Treatment outcomes

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NEUROFIBROMA; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RADIOSURGERY; RADIOTHERAPY; SCHOOL CHILD; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

ADULT; CHILD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MAXILLARY SINUS NEOPLASMS; NEUROFIBROMA; ORBITAL NEOPLASMS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PHARYNGEAL NEOPLASMS; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SPINAL CORD NEOPLASMS; SPINAL NERVE ROOTS; THORACIC NERVES; TREATMENT OUTCOME;

EID: 20444413383     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000156923.52181.3d     Document Type: Article

References (32)

1. Woodruff JM. Pathology of major peripheral nerve sheath neoplasms. In: Weiss SW, Brooks JSJ, eds. Soft Tissue Tumors. Baltimore: Lippincott Williams & Wilkins; 1996:129-161.
2. Lott IT, Richardson EP. Neuropathological findings and the biology of neurofibromatosis. Adv Neurol. 1981;29:23-32.
3. Scheithauer BW, Woodruff JM, Erlandson RA. Tumors of the peripheral nervous system. In: Rosai JR, Sobin LH, eds. Atlas of Tumor Pathology, ed. 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1999.
4. Order SE, Donaldson SS. Radiotherapy of Benign Diseases: A Clinical Guide. Heidelberg: Springer Verlag; 1990.
5. Riccardi VM. Neurofibromatosis: Past, present, and future. N Engl J Med. 1991;324:1283-1285.
6. Freidman JM, Gutmann DH, MacCollin M, et al. Neurofibromatosis: Phenotype, Natural History and Pathogenesis, 3rd ed. Baltimore: Johns Hopkins Press; 1999.
7. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575-578.
8. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51-57.
9. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608-614.
10. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70:138-143.
11. Listernick R, Charrow J, Greenwald MJ, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: longitudinal study. J Pediatr. 1994;125:63-66.
12. Gutmann D. The neurofibromatoses: when less is more. Hum Mol Genet. 2001;10:747-755.
13. Cawthon RM, Weiss R, Xu GF, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell. 1990;62:193-201.
14. Xu G, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevesiae. Cell. 1990;63:835-841.
15. Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type I gene encodes a protein related to GAP. Cell. 1990;62:599-608.
16. Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990;63:843-849.
17. Sherman LS, Atit R, Rosenbaum TCAD, et al. Single cell Ras-GTP reveals altered ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J Biol Chem. 2000;275:30740-30745.
18. Korf BR. Plexiform neurofibromas. Am J Med Genet. 1999;89:31-37.
19. North KN. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol. 1993;8:395-402.
20. Cnossen MH, de Goede-Bolder A, van den Broek KM, et al. A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child. 1998;78:408-412.
21. Waggoner DJ, Towbin J, Gottesman G, et al. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet. 2000;92:132-135.
22. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain. 1988;111:1355-1381.
23. Wanebo JE, Malik JM, VanderBerg SR, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993;71:1247-1253.
24. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer. 1986;57:2006-2021.
25. Leroy K, Dumas V, Martin-Garcia N, et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: clinicopathologic and molecular study of 17 patients. Arch Dermatol. 2001;137:908-913.
26. Thakkar SD, Feigen U, Mautner VF. Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology. 1999;41:625-629.
27. Korf BR. Determination of end points for treatment of neurofibromatosis 1. J Child Neurol. 2002;17:642-645.
28. Rosser T, Packer RJ. Neurofibromas in children with neurofibromatosis 1. J Child Neurol. 2002;17:585-591.
29. Needle MN, Cnaan A, Dattilo J, et al. Prognostic signs in the surgical management of plexiform neurofibromas: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr. 1997;131: 678-682.
30. Greenberg HM, Goebel R, Weichselbaum RR, et al. Radiation therapy in the treatment of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 1981;7:305-310.
31. Suit HD, Russell WO. Radiation therapy of soft tissue sarcoma. Cancer. 1975;36:759-764.
32. Robertson TC, Buck DA, Schmidt-Ullrich R, et al. Isolated plexiform neurofibroma: treatment with three-dimensional conformal radiotherapy. Laryngoscope. 2004;114:1139-1142.